Compound ID | 1237
ETX0282CPDP (ETX0282 + cefpodoxime)
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Complicated UTIs (Enterobacteriaceaeincluding ESBL-producing and CRE) |
| Combined with other compounds: | Yes |
| Institute where first reported: | Entasis Therapeutics |
| Highest developmental phase: | Phase 1 |
| Development status: | Active |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6335986#section=3D-Conformer |
| Guide to Pharmacology: | ETX0282 |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.